EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiac troponin at the point of care in acute and chronic coronary syndromes

Michael McDermott iD, Yong Yong Tew, Jamie G Cooper, Deepak Harry, Nicholas L Mills

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16503 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Michael McDermott und 4 weiteren Autor:innen. Beteiligte Einrichtung: BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Point-of-Care Systems, Troponin, Troponin T. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation Clinical Research Scholarship, Chair Award, Programme Grant, Research Excellence Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐sensitivity cardiac troponin (hs‐cTn) assays are integral to the assessment of patients with acute chest pain where prompt and accurate diagnosis of myocardial infarction enables timely delivery of potentially life‐saving treatment. In the Emergency Department, implementation of central laboratory hs‐cTn assays has reduced length of stay and unnecessary hospital admission. Recently hs‐cTn assays have become available on point‐of‐care (POC) platforms that have equivalent analytical and diagnostic performance to central laboratory platforms but can deliver results more rapidly to guide decisions in real‐time. These assays have the potential to further accelerate care in the Emergency Department and to facilitate the assessment of patients with suspected acute coronary syndromes in pre‐hospital settings, primary care and the out‐patient clinic. Greater accessibility to testing could broaden the role of hs‐cTn to improve the risk stratification of patients with new onset exertional angina and chronic coronary syndromes. Whilst hs‐cTn assays are already available for use at the point‐of‐care, prospective studies are required to determine the clinical and cost‐effectiveness of testing in patients with acute and chronic coronary syndromes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromePoint-of-Care SystemsTroponinTroponin TMyocardial InfarctionPoint-of-Care TestingHumansBiomarkersEmergency Service, HospitalChronic DiseaseChest Pain

Stichwörter der Autor:innen

cardiovascular diseasemacrovascular diseasereal‐world evidencesystematic review

Substanzen

BiomarkersTroponinTroponin T

Autor:innen und Institutionen

  • BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Aberdeen Royal Infirmary, Aberdeen, UK.
  • Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Usher Institute, University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Michael McDermott

Förderung

  • British Heart Foundation Clinical Research Scholarship
  • Chair Award, Programme Grant
  • Research Excellence Award
  • British Heart Foundation

Zitieren

APA

McDermott, M., Tew, Y. Y., Cooper, J. G., Harry, D., & Mills, N. L. (2025). Cardiac troponin at the point of care in acute and chronic coronary syndromes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16503

Vancouver

McDermott M, Tew YY, Cooper JG, Harry D, Mills NL. Cardiac troponin at the point of care in acute and chronic coronary syndromes. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16503

BibTeX
@article{McDermott2025,
  author = {McDermott, Michael and Tew, Yong Yong and Cooper, Jamie G and Harry, Deepak and Mills, Nicholas L},
  title = {Cardiac troponin at the point of care in acute and chronic coronary syndromes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16503}
}
Kostenlos starten →